Matthew D. Morin

561 total citations
10 papers, 444 citations indexed

About

Matthew D. Morin is a scholar working on Immunology, Organic Chemistry and Microbiology. According to data from OpenAlex, Matthew D. Morin has authored 10 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Organic Chemistry and 3 papers in Microbiology. Recurrent topics in Matthew D. Morin's work include Immune Response and Inflammation (6 papers), Asymmetric Synthesis and Catalysis (4 papers) and Antimicrobial Peptides and Activities (3 papers). Matthew D. Morin is often cited by papers focused on Immune Response and Inflammation (6 papers), Asymmetric Synthesis and Catalysis (4 papers) and Antimicrobial Peptides and Activities (3 papers). Matthew D. Morin collaborates with scholars based in United States and Israel. Matthew D. Morin's co-authors include Lijing Su, Bruce Beutler, Brian T. Jones, Dale L. Boger, Eva Marie Y. Moresco, Ying Wang, Scott D. Rychnovsky, Hexin Shi, Hong Zhang and Xiaoming Zhan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and The Journal of Immunology.

In The Last Decade

Matthew D. Morin

9 papers receiving 442 citations

Peers

Matthew D. Morin

IMMUN

MB

OC

EPIDE

MICRO

Peter Stütz Austria

Nicola Relitti Italy

Jean‐Marc Billod Spain

Steven Fletcher United States

Xiaohong Cen China

Caifeng Chen China

Fabio A. Facchini Italy

Clover Ching Man Wong Hong Kong

San San Yi United States

Kendal Ryter United States

Peter Stütz Austria

Matthew D. Morin

187 ×0.7

IMMUN

138 ×1.0

MB

47 ×0.5

OC

36 ×0.6

EPIDE

19 ×0.4

MICRO

Citations per year, relative to Matthew D. Morin Matthew D. Morin (= 1×) peers Peter Stütz

Countries citing papers authored by Matthew D. Morin

Since Specialization

Citations

This map shows the geographic impact of Matthew D. Morin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew D. Morin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew D. Morin more than expected).

Fields of papers citing papers by Matthew D. Morin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew D. Morin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew D. Morin. The network helps show where Matthew D. Morin may publish in the future.

Co-authorship network of co-authors of Matthew D. Morin

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew D. Morin. A scholar is included among the top collaborators of Matthew D. Morin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew D. Morin. Matthew D. Morin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Su, Lijing, Ying Wang, Junmei Wang, et al.. (2019). Structural Basis of TLR2/TLR1 Activation by the Synthetic Agonist Diprovocim. Journal of Medicinal Chemistry. 62(6). 2938–2949. 65 indexed citations

2.

Morin, Matthew D., Ying Wang, Brian T. Jones, et al.. (2018). Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor Agonists. Journal of the American Chemical Society. 140(43). 14440–14454. 42 indexed citations

3.

Wang, Ying, Lijing Su, Matthew D. Morin, et al.. (2018). Adjuvant effect of the novel TLR1/TLR2 agonist Diprovocim synergizes with anti–PD-L1 to eliminate melanoma in mice. Proceedings of the National Academy of Sciences. 115(37). E8698–E8706. 98 indexed citations

4.

Su, Lijing, Ying Wang, Matthew D. Morin, et al.. (2017). Structural characterization of TLRs with novel agonists. The Journal of Immunology. 198(Supplement_1). 129.4–129.4.

5.

Wang, Ying, Lijing Su, Matthew D. Morin, et al.. (2016). TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS. Proceedings of the National Academy of Sciences. 113(7). E884–93. 135 indexed citations

6.

Morin, Matthew D., Ying Wang, Brian T. Jones, et al.. (2016). Discovery and Structure–Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists. Journal of Medicinal Chemistry. 59(10). 4812–4830. 28 indexed citations

7.

Perry, Matthew A., Matthew D. Morin, B. W. Slafer, & Scott D. Rychnovsky. (2012). Total Synthesis of Lepadiformine Alkaloids using N-Boc α-Amino Nitriles as Trianion Synthons. The Journal of Organic Chemistry. 77(7). 3390–3400. 31 indexed citations

8.

Perry, Matthew A., Matthew D. Morin, B. W. Slafer, Scott A. Wolckenhauer, & Scott D. Rychnovsky. (2010). Fully Substituted Carbon Centers by Diastereoselective Spirocyclization: Stereoselective Synthesis of (+)-Lepadiformine C. Journal of the American Chemical Society. 132(28). 9591–9593. 25 indexed citations

9.

Morin, Matthew D. & Scott D. Rychnovsky. (2005). Reductive Spiroannulation of Nitriles with Secondary Electrophiles. Organic Letters. 7(10). 2051–2053. 12 indexed citations

10.

NICAISE, O. J.‐C., et al.. (2003). Stable enols from Grignard addition to 1,2-diesters: serendipity rules. Tetrahedron. 59(34). 6433–6443. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact